Actively Recruiting
Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women
Led by Weill Medical College of Cornell University · Updated on 2026-04-22
75
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
W
Weill Medical College of Cornell University
Lead Sponsor
N
National Academy of Medicine
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to improve the detection of high blood pressure and related pregnancy health issues in pregnant refugee women using digital health tracking. The study focuses on testing and refining a digital monitoring system to identify gestational hypertension and associated risks like preeclampsia. The goal is to enhance diagnosis accuracy compared to clinical standards, ultimately supporting targeted treatment for this population. Participants will use digital devices such as smartwatches and electronic blood pressure monitors to collect health data at home over 24 months. They will record weekly blood pressure readings with devices like the Nokia-Withings BPM Connect, entering data into a smartphone app. Continuous tracking via Apple Watches and Fitbit Versa 3 will monitor heart rate, activity, and sleep. The study includes baseline and follow-up in-person visits with surveys to assess health, stress, and related risks. Throughout the study, participants will complete questionnaires, regular blood pressure checks, pain and trauma assessments, and clinical monitoring. Researchers will evaluate the digital system's ability to detect gestational hypertension with high sensitivity and track comorbid conditions. They will also assess referrals to healthcare providers and retention of participant contact. The main outcome is the system's digital sensitivity in detecting hypertension, monitored over a maximum 13-month enrollment period.
CONDITIONS
Brief Title
Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant
- Refugee, asylum seeking, or asylee as designated by the U.S. Government
- 18 years of age or older
- Has a personal smartphone
You will not qualify if you...
- Unable to provide informed consent
- Considered in an extremely vulnerable position by the principal investigator and not suited for research participation
- Plans to move from the New York City area within the next 24 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 13 months
Participants are monitored through digital health tracking with devices to collect cardiovascular and health data, as well as complete questionnaires and assessments.
Weekly visits for blood pressure measurements and ongoing passive data collection via smartwatches
Trial Site Locations
Total: 1 location
1
Weill Cornell Medicine
New York, New York, United States, 10065
Actively Recruiting
Research Team
G
Gunisha Kaur, MA, MD
M
Michele Steinkamp, RN
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here